Medical and health workers have found a drug that can treat refractory abscess bacteria that send tens of thousands of people to emergency rooms.

Researchers from the University of British Columbia used a peptide, or mini protein, to prevent drug-resistant bacteria from developing abscesses or purulent lesions. The polypeptide blocks the secretion of bacteria by interfering with their stress response.

Abscesses are bacterial - mediated tissue lesions that cause about 3.2 million people to enter the emergency room each year. This is because these bacteria are resistant to antibiotics and can only be treated by reducing infection and purulent discharge.

"Abscesses can occur almost anywhere in the body, and antibiotics usually don't work," said Bob Hancock, a professor of Microbiology at Columbia University. And we have a new idea to use polypeptides to treat it, because its mechanism is completely different from that of antibiotics

Hancock and his colleagues found that bacteria in abscesses grow under stress. They use a peptide to interfere with this bacterial stress response, so they can treat mice abscesses.

Bacteria can be divided into Gram-positive and Gram-negative bacteria according to their cell wall structure. They are also resistant to a variety of antibiotics because of their cell wall. The peptide has good effect on both Gram-positive and Gram-negative bacteria.

Shengnuo bio PRODUCT

Best sales manager contact

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.